Ryvu Therapeutics

Ryvu Therapeutics

Develop therapeutics that address clinical limitations of current treatments in oncology. Learn more

Launch date
Employees
Market cap
$315m
Enterprise valuation
$265m (Public information from Sep 2024)
Kraków Lesser Poland Voivodeship (HQ)
Authorizing premium user...